Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Radiopharm Theranostics Announces 50% Enrollment in Phase 2b Clinical Trial of RAD101 Imaging in Brain Metastases
-
Industry-first SDV Maturity Framework brings clarity and urgency to auto industry
-
SAIHEAT LIMITED Secures Patent for “Waste Heat Recovery System and Method”, Deepening in Chip Cooling Waste Heat Recovery Field and Empowering Green Development and R&D Upgrade with Technologi
-
J & J Snack Foods Reports Fiscal 2025 Fourth Quarter and Full-Year Results
-
Imbria Pharmaceuticals Announces Extension of Series B Financing to Advance Ninerafaxstat for Cardiovascular Diseases
-
Maxus Mining Initiates Historical Desktop Compilation on Four Critical Minerals Projects in British Columbia, Canada
-
Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit
-
HomeTrust Bank Recognized Nationally with Three Workplace Awards, Advances to Top 100 Most Loved Workplace®
-
Liberty Defense Announces Contract Award for Multiple HEXWAVE™ Walkthrough Screening Systems from a U.S. State Capitol Complex
-
Nuvini Appoints AI Industry Leader Phoebe Wang to Board of Directors
-
Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences
-
Annovis Reports New Biomarker Data Linking Amyloid Co-Pathology to Accelerated Cognitive Decline in Parkinson's Patients
-
Metagenomi to Present at Jefferies Global Healthcare Conference in London
-
Aeries Technology featured in Everest Group’s PEAK Matrix® for GCC Setup Capabilities 2025 for the Second Year Running
-
EverCommerce to Present at the RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference
-
Annovis Reports New Biomarker Data Linking Amyloid Co-Pathology to Accelerated Cognitive Decline in Parkinson's Patients
-
FundGuard Appoints Industry Veteran Simon Behan as Chief Commercial Officer to Accelerate Global Growth
-
Celestica Introduces the SD6300 Platform Aiming to Deliver Maximum Storage Density for Enterprise and AI Applications
-
HomesToLife Reports 71% Increase in Net Profit to US$13.1 Million for 9M 2025
-
Changan Automobile Advocates for a Fair and Sustainable Automotive Future at COP30
-
Hear the Future: ELEHEAR Launches Black Friday Deal on AI Hearing Aids
-
CLOSEMATE Launches Global Comfortwear Expansion After Amazon Bestseller Success
-
SAIHEAT LIMITED Secures Patent for “Waste Heat Recovery System and Method”, Deepening in Chip Cooling Waste Heat Recovery Field and Empowering Green Development and R&D Upgrade with Technological
-
Datavault AI Signs Multi-Million Dollar Tokenization Services Agreement With Triton Geothermal to Provide Significant Revenue Opportunities
-
Mavenir to Deliver Corporate Update and AI Vision at Annual Global Analyst Event
-
Kelly Education Introduces First-of-Its-Kind LEARN Standards for Substitute Teachers and Paraeducators
-
ProPhase Labs Urges Shareholders to Vote by November 23 on Proxy Proposals
-
Curium Consolidates New Biopharma Business and Sets Up Global Headquarters in Boston, Massachusetts
-
Algoma Steel Completes $500 Million Government Financing Transaction
-
PetVivo Holdings Announces Digital Landia’s Publication of Technical Whitepaper Validating AgenticPet AI Framework Under Exclusive 10-Year Licensing Agreement
-
Autonomix Medical, Inc. Reports Positive Subgroup Results Demonstrating Sustained Improvements in Quality of Life from Post Hoc Analysis of Pancreatic Cancer PoC Study
-
Porosome Therapeutics Publishes Preclinical Findings Demonstrating Restoration of Neuronal Secretion and Reversal of Alzheimer’s Disease Pathology Following Porosome Reconstitution Therapy
-
NextCure Announces Closing of $21.5 Million PIPE Financing in Advance of First Half 2026 Phase 1 POC Data Readouts
-
T-knife Therapeutics Files Clinical Trial Application for Phase 1 ATLAS Trial for TK-6302, a Supercharged PRAME-targeted T Cell Receptor Therapy
-
Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit
-
Gabelli Launches New Exchange-Traded Fund: Gabelli High Income ETF (GBHI)
-
FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children Ages 2 to 5
-
Calidi Biotherapeutics Announces Exclusive Live Investor Webinar and Q&A Session on November 19, 2025
-
Kratos Opens New 60,000 Sq Ft Jerusalem Facility for Microwave Electronics Division
-
Algorhythm Holdings to Announce its Financial Results for the Third Quarter 2025
-
Solid Biosciences Announces Licensing Agreement with Andelyn Biosciences for the Use of Proprietary Next-Generation Capsid AAV-SLB101
-
Acumen Pharmaceuticals Announces First Participant Dosed in Phase 2 Open-Label Extension Study of Sabirnetug in People with Early Alzheimer’s Disease
-
GS E&C Strengthens Partnership with Amogy Through Strategic Investment to Accelerate Carbon-Free Distributed Power Innovation
-
Gentex Announces Acquisition of BioConnect
-
Siebert Launches Siebert.Pro for Active, Self-Directed Investors
-
Cerevance to Participate in the TD Cowen Treatment Advancements in Obesity and Related Disorders Summit
-
Duke Robotics Reports Third Quarter 2025 Financial Results and Provides Business Update
-
ASML reports transactions under its current share buyback program
-
Philips brings AI into the procedure room to assist doctors during heart valve repair
-
STMicroelectronics announces status of common share repurchase program

